Editorial: DNA repair and nucleic acid therapeutics in cancer.
作者信息
Sobol Robert W
机构信息
Department of Pathology and Laboratory Medicine, Warren Alpert Medical School & Legorreta Cancer Center, Brown University, Providence, RI 02912, USA.
出版信息
NAR Cancer. 2023 Aug 28;5(3):zcad044. doi: 10.1093/narcan/zcad044. eCollection 2023 Sep.
Abstract
摘要
相似文献
1
Editorial: DNA repair and nucleic acid therapeutics in cancer.
NAR Cancer. 2023 Aug 28;5(3):zcad044. doi: 10.1093/narcan/zcad044. eCollection 2023 Sep.
2
Editorial: Nucleic acid-based aptamers in therapeutics and diagnostics.
Front Chem. 2024 Jan 3;11:1355870. doi: 10.3389/fchem.2023.1355870. eCollection 2023.
3
Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways.
Front Mol Biosci. 2022 Feb 15;9:858514. doi: 10.3389/fmolb.2022.858514. eCollection 2022.
4
Nucleic acid-based fluorescent methods for the determination of DNA repair enzyme activities: A review.
Anal Chim Acta. 2019 Jul 4;1060:30-44. doi: 10.1016/j.aca.2018.12.055. Epub 2019 Jan 9.
5
Editorial for the Special Issue on "Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials".
Nanomaterials (Basel). 2019 Jun 30;9(7):951. doi: 10.3390/nano9070951.
6
Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers.
Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2220787120. doi: 10.1073/pnas.2220787120. Epub 2023 May 15.
7
miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.
Mol Ther. 2020 Jun 3;28(6):1494-1505. doi: 10.1016/j.ymthe.2020.04.001. Epub 2020 Apr 11.
8
Editorial: Nucleic Acids Research and Nucleic Acid Therapeutics.
Nucleic Acids Res. 2018 Feb 28;46(4):1563-1564. doi: 10.1093/nar/gky059.
9
Nucleic Acid Immunotherapeutics for Cancer.
ACS Appl Bio Mater. 2020 May 18;3(5):2838-2849. doi: 10.1021/acsabm.0c00101. Epub 2020 Mar 16.
10
Editorial: Structural biology of nucleic acid replication, recombination and repair.
Front Mol Biosci. 2023 Mar 15;10:1155089. doi: 10.3389/fmolb.2023.1155089. eCollection 2023.
本文引用的文献
1
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors.
NAR Cancer. 2023 Aug 21;5(3):zcad043. doi: 10.1093/narcan/zcad043. eCollection 2023 Sep.
2
R-loops, type I topoisomerases and cancer.
NAR Cancer. 2023 Mar 3;5(1):zcad013. doi: 10.1093/narcan/zcad013. eCollection 2023 Mar.
3
Replication DNA polymerases, genome instability and cancer therapies.
NAR Cancer. 2023 Jun 28;5(3):zcad033. doi: 10.1093/narcan/zcad033. eCollection 2023 Sep.
4
DNA mismatch repair in cancer immunotherapy.
NAR Cancer. 2023 Jun 13;5(3):zcad031. doi: 10.1093/narcan/zcad031. eCollection 2023 Sep.
5
A multi-scale map of protein assemblies in the DNA damage response.
Cell Syst. 2023 Jun 21;14(6):447-463.e8. doi: 10.1016/j.cels.2023.04.007. Epub 2023 May 22.
6
Current proteomics methods applicable to dissecting the DNA damage response.
NAR Cancer. 2023 May 19;5(2):zcad020. doi: 10.1093/narcan/zcad020. eCollection 2023 Jun.
7
Molecular mechanisms protecting centromeres from self-sabotage and implications for cancer therapy.
NAR Cancer. 2023 May 9;5(2):zcad019. doi: 10.1093/narcan/zcad019. eCollection 2023 Jun.
8
Recent advancements in the structural biology of human telomerase and their implications for improved design of cancer therapeutics.
NAR Cancer. 2023 Mar 3;5(1):zcad010. doi: 10.1093/narcan/zcad010. eCollection 2023 Mar.
9
Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability.
NAR Cancer. 2023 Feb 20;5(1):zcad009. doi: 10.1093/narcan/zcad009. eCollection 2023 Mar.
10
APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target.
NAR Cancer. 2023 Feb 6;5(1):zcad006. doi: 10.1093/narcan/zcad006. eCollection 2023 Mar.
Zotero 插件